546 related articles for article (PubMed ID: 30446929)
1. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
[TBL] [Abstract][Full Text] [Related]
2. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.
Róka R; Ait-Belgnaoui A; Salvador-Cartier C; Garcia-Villar R; Fioramonti J; Eutamène H; Bueno L
Gut; 2007 Aug; 56(8):1072-8. PubMed ID: 17309885
[TBL] [Abstract][Full Text] [Related]
4. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome.
Han W; Wang Z; Lu X; Guo C
Neurogastroenterol Motil; 2012 Feb; 24(2):113-9, e82. PubMed ID: 22151913
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
[TBL] [Abstract][Full Text] [Related]
6. Increased VGLUT3 involved in visceral hyperalgesia in a rat model of irritable bowel syndrome.
Yang CQ; Duan LP; Qiao PT; Zhao L; Guo LL
World J Gastroenterol; 2015 Mar; 21(10):2959-66. PubMed ID: 25780293
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E
Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
[TBL] [Abstract][Full Text] [Related]
8. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients.
Wang P; Chen FX; Du C; Li CQ; Yu YB; Zuo XL; Li YQ
Sci Rep; 2015 May; 5():10121. PubMed ID: 25998025
[TBL] [Abstract][Full Text] [Related]
9. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.
Yang B; Zhou X; Lan C
BMC Gastroenterol; 2015 Apr; 15():43. PubMed ID: 25886744
[TBL] [Abstract][Full Text] [Related]
10. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor.
Hu X; Zhang X; Han B; Bei W
BMC Complement Altern Med; 2013 Oct; 13():246. PubMed ID: 24088410
[TBL] [Abstract][Full Text] [Related]
12. Multispecies probiotic protects gut barrier function in experimental models.
Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
[TBL] [Abstract][Full Text] [Related]
13. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.
Chen B; Zhu S; Du L; He H; Kim JJ; Dai N
Scand J Gastroenterol; 2017 Oct; 52(10):1065-1071. PubMed ID: 28679338
[TBL] [Abstract][Full Text] [Related]
14. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
Gecse K; Róka R; Ferrier L; Leveque M; Eutamene H; Cartier C; Ait-Belgnaoui A; Rosztóczy A; Izbéki F; Fioramonti J; Wittmann T; Bueno L
Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome.
Long Y; Wang W; Wang H; Hao L; Qian W; Hou X
J Gastroenterol Hepatol; 2012 May; 27(5):935-44. PubMed ID: 22141367
[TBL] [Abstract][Full Text] [Related]
16. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
17. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.
Chen J; Zhang Y; Deng Z
BMC Gastroenterol; 2012 Jul; 12():91. PubMed ID: 22816602
[TBL] [Abstract][Full Text] [Related]
19. GPER-mediated, oestrogen-dependent visceral hypersensitivity in stressed rats is associated with mast cell tryptase and histamine expression.
Xu S; Wang X; Zhao J; Yang S; Dong L; Qin B
Fundam Clin Pharmacol; 2020 Aug; 34(4):433-443. PubMed ID: 31967341
[TBL] [Abstract][Full Text] [Related]
20. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model.
Hong KB; Seo H; Lee JS; Park Y
BMC Complement Altern Med; 2019 Jul; 19(1):195. PubMed ID: 31366385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
